|
|
| Line 32: |
Line 32: |
| |} | | |} |
|
| |
|
| ==WHO Essential and Desirable Genetic Diagnostic Criteria==
| |
| <span style="color:#0070C0">(''Instructions: The table will have the diagnostic criteria from the WHO book <u>autocompleted</u>; remove any <u>non</u>-genetics related criteria. If applicable, add text about other classification'' ''systems that define this entity and specify how the genetics-related criteria differ.'')</span>
| |
| {| class="wikitable"
| |
| |+
| |
| |WHO Essential Criteria (Genetics)*
| |
| |Detection of a tyrosine kinase fusion gene not classified under specific unique entities (''PDGFRA, PDGFRB, FGFR1, JAK2, FLT3, ETV6::ABL1'').
| |
| |-
| |
| |WHO Desirable Criteria (Genetics)*
| |
| |Cytogenetic translocation suggesting a potential involvement of a tyrosine kinase gene, with selection of a FISH break-apart probe or another molecular assay for confirmation.
| |
| |-
| |
| |Other Classification
| |
| |Other desirable criteria: Presence of eosinophilia.
| |
| |}
| |
| <nowiki>*</nowiki>Note: These are only the genetic/genomic criteria. Additional diagnostic criteria can be found in the [https://tumourclassification.iarc.who.int/home <u>WHO Classification of Tumours</u>].
| |
| ==Related Terminology== | | ==Related Terminology== |
|
| |
|
